Last reviewed · How we verify
Squamous cell carcinoma of lung
Approved treatments
- Opdivo · Bristol-Myers Squibb
Opdivo works by blocking the PD-1 receptor on immune cells, allowing them to attack cancer cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Squamous cell carcinoma of lung patent landscape — cliff calendar, originator estates, attackable patents
- Squamous cell carcinoma of lung treatment landscape brief
- Squamous cell carcinoma of lung treatment updates RSS
Frequently asked questions about Squamous cell carcinoma of lung
What drugs treat Squamous cell carcinoma of lung?
Tracked treatments include Opdivo.
What is the treatment for Squamous cell carcinoma of lung?
Standard treatment for Squamous cell carcinoma of lung includes Opdivo. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Squamous cell carcinoma of lung patent cliff · Squamous cell carcinoma of lung CI report
- Treatment: Opdivo · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing